Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Biol Chem ; 276(48): 45051-8, 2001 Nov 30.
Artigo em Inglês | MEDLINE | ID: mdl-11560937

RESUMO

The direct inhibition of N- and P/Q-type calcium channels by G protein betagamma subunits is considered a key mechanism for regulating presynaptic calcium levels. We have recently reported that a number of features associated with this G protein inhibition are dependent on the G protein beta subunit isoform (Arnot, M. I., Stotz, S. C., Jarvis, S. E., Zamponi, G. W. (2000) J. Physiol. (Lond.) 527, 203-212; Cooper, C. B., Arnot, M. I., Feng, Z.-P., Jarvis, S. E., Hamid, J., Zamponi, G. W. (2000) J. Biol. Chem. 275, 40777-40781). Here, we have examined the abilities of different types of ancillary calcium channel beta subunits to modulate the inhibition of alpha(1B) N-type calcium channels by the five known different Gbeta subunit subtypes. Our data reveal that the degree of inhibition by a particular Gbeta subunit is strongly dependent on the specific calcium channel beta subunit, with N-type channels containing the beta(4) subunit being less susceptible to Gbetagamma-induced inhibition. The calcium channel beta(2a) subunit uniquely slows the kinetics of recovery from G protein inhibition, in addition to mediating a dramatic enhancement of the G protein-induced kinetic slowing. For Gbeta(3)-mediated inhibition, the latter effect is reduced following site-directed mutagenesis of two palmitoylation sites in the beta(2a) N-terminal region, suggesting that the unique membrane tethering of this subunit serves to modulate G protein inhibition of N-type calcium channels. Taken together, our data suggest that the nature of the calcium channel beta subunit present is an important determinant of G protein inhibition of N-type channels, thereby providing a possible mechanism by which the cellular/subcellular expression pattern of the four calcium channel beta subunits may regulate the G protein sensitivity of N-type channels expressed at different loci throughout the brain and possibly within a neuron.


Assuntos
Canais de Cálcio/química , Animais , Western Blotting , Encéfalo/metabolismo , Canais de Cálcio/metabolismo , Canais de Cálcio/fisiologia , Linhagem Celular , Proteínas de Fluorescência Verde , Humanos , Cinética , Proteínas Luminescentes/metabolismo , Microscopia Confocal , Mutagênese Sítio-Dirigida , Neurônios/metabolismo , Ácido Palmítico/metabolismo , Técnicas de Patch-Clamp , Ligação Proteica , Isoformas de Proteínas , Estrutura Terciária de Proteína , Ratos , Proteínas Recombinantes de Fusão/metabolismo , Fatores de Tempo , Transfecção
2.
J Neurosci Res ; 64(6): 617-25, 2001 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-11398186

RESUMO

Diazepam is widely prescribed as an anxiolytic but its therapeutic application is limited because with daily use tolerance develops to certain aspects of its pharmacological profile. We compared the effects of two dosing paradigms on GABA(A) receptor gene expression and benzodiazepine binding characteristics. Equivalent daily doses of 15 mg/kg/day diazepam were delivered either via constant infusion or daily subcutaneous injection for 14 days. The two distinct treatment regimes produced significantly different changes in GABA(A) receptor alpha4-, beta2-, beta3- and gamma1-subunit mRNA steady-state levels. Similar changes in the GABA enhancement of flunitrazepam binding and the BZ3/BZ2 subtype ratio determined ex vivo were produced, however, significant differences were found in [(3)H]-Ro 15-4513 binding between cortical tissue from diazepam injected animals compared with diazepam infused animals. Our data suggest that it is the diurnal fluctuations in receptor occupancy that are responsible for the different effects produced by these two dosing regimes.


Assuntos
Córtex Cerebral/fisiologia , Diazepam/farmacologia , Moduladores GABAérgicos/farmacologia , Receptores de GABA-A/genética , Marcadores de Afinidade/farmacologia , Animais , Azidas/farmacologia , Benzodiazepinas/farmacologia , Córtex Cerebral/efeitos dos fármacos , Relação Dose-Resposta a Droga , Expressão Gênica/efeitos dos fármacos , Bombas de Infusão Implantáveis , Injeções Subcutâneas , Masculino , RNA Mensageiro/análise , Ratos , Ratos Sprague-Dawley , Receptores de GABA-A/metabolismo , Trítio
3.
Neuron ; 28(1): 195-204, 2000 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11086994

RESUMO

Cysteine string proteins (CSPs) are secretory vesicle proteins bearing a "J domain" and a palmitoylated cysteine-rich "string" region that are critical for neurotransmitter release. The precise role of CSP in neurotransmission is controversial. Here, we demonstrate a novel interaction between CSP, receptor-coupled trimeric GTP binding proteins (G proteins), and N-type Ca2+ channels. G. subunits interact with the J domain of CSP in an ATP-dependent manner; in contrast, Gbetagamma subunits interact with the C terminus of CSP in both the presence and absence of ATP. The interaction of CSP with both G proteins and N-type Ca2+ channels results in a tonic G protein inhibition of the channels. In view of the crucial importance of N-type Ca2+ channels in presynaptic vesicle release, our data attribute a key role to CSP in the fine tuning of neurotransmission.


Assuntos
Canais de Cálcio Tipo N/metabolismo , Proteínas de Ligação ao GTP/metabolismo , Proteínas de Membrana/metabolismo , Trifosfato de Adenosina/metabolismo , Animais , Bloqueadores dos Canais de Cálcio/farmacologia , Canais de Cálcio Tipo N/efeitos dos fármacos , Linhagem Celular , Reagentes de Ligações Cruzadas/farmacologia , Proteínas de Ligação ao GTP/genética , Proteínas de Ligação ao GTP/farmacologia , Proteínas de Choque Térmico HSP40 , Hipocampo/química , Hipocampo/metabolismo , Humanos , Immunoblotting , Técnicas In Vitro , Transporte de Íons/efeitos dos fármacos , Proteínas de Membrana/efeitos dos fármacos , Modelos Moleculares , Técnicas de Patch-Clamp , Cloreto de Potássio/farmacologia , Ligação Proteica/efeitos dos fármacos , Subunidades Proteicas , Ratos
4.
J Biol Chem ; 275(52): 40777-81, 2000 Dec 29.
Artigo em Inglês | MEDLINE | ID: mdl-11053424

RESUMO

The modulation of N-type calcium current by protein kinases and G-proteins is a factor in the fine tuning of neurotransmitter release. We have previously shown that phosphorylation of threonine 422 in the alpha(1B) calcium channel domain I-II linker region resulted in a dramatic reduction in somatostatin receptor-mediated G-protein inhibition of the channels and that the I-II linker consequently serves as an integration center for cross-talk between protein kinase C (PKC) and G-proteins (Hamid, J., Nelson, D., Spaetgens, R., Dubel, S. J., Snutch, T. P., and Zamponi, G. W. (1999) J. Biol. Chem. 274, 6195-6202). Here we show that opioid receptor-mediated inhibition of N-type channels is affected to a lesser extent compared with that seen with somatostatin receptors, hinting at the possibility that PKC/G-protein cross-talk might be dependent on the G-protein subtype. To address this issue, we have examined the effects of four different types of G-protein beta subunits on both wild type and mutant alpha(1B) calcium channels in which residue 422 has been replaced by glutamate to mimic PKC-dependent phosphorylation and on channels that have been directly phosphorylated by protein kinase C. Our data show that phosphorylation or mutation of residue 422 antagonizes the effect of Gbeta(1) on channel activity, whereas Gbeta(2), Gbeta(3), and Gbeta(4) are not affected. Our data therefore suggest that the observed cross-talk between G-proteins and protein kinase C modulation of N-type channels is a selective feature of the Gbeta(1) subunit.


Assuntos
Canais de Cálcio Tipo N/metabolismo , Proteínas de Ligação ao GTP/fisiologia , Proteína Quinase C/fisiologia , Proteínas de Ligação ao GTP/química , Humanos , Fosforilação , Isoformas de Proteínas/fisiologia , Subunidades Proteicas , Transmissão Sináptica
5.
J Physiol ; 527 Pt 2: 203-12, 2000 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-10970423

RESUMO

Using transient calcium phosphate transfection into the human embryonic kidney tsa-201 cell line and subsequent whole-cell patch-clamp protocols, we examined the tonic modulation of cloned N- and P/Q-type calcium channels by five different G protein beta subunits via strong depolarizing voltage prepulses. For N- and P/Q-type channels, the magnitude of inhibition was dependent on the Gbeta subtype co-expressed. Both the absolute and relative magnitudes of Gbeta subunit-induced inhibition of P/Q-type channels differed from those observed with the N-type channel. For each calcium channel subtype, kinetics of both the prepulse-mediated recovery from inhibition and the re-inhibition following the prepulse were examined for each of the Gbeta subunits by varying either the duration between the pre- and the test pulse or the length of the prepulse. For each channel subtype, we observed a differential Gbeta subunit rank order with regard to the rates of re-inhibition and recovery from inhibition. On average, P/Q-type channels exhibited more rapid rates of recovery from inhibition than those observed with N-type channels. Different Gbeta subtypes mediated different degrees of slowing of activation kinetics. The differential modulation of P/Q- and N-type channels by various Gbeta subtypes may provide a mechanism for fine tuning the amount of calcium entering the presynaptic nerve termini.


Assuntos
Bloqueadores dos Canais de Cálcio/farmacologia , Canais de Cálcio Tipo N/efeitos dos fármacos , Canais de Cálcio Tipo Q/efeitos dos fármacos , Proteínas Heterotriméricas de Ligação ao GTP/farmacologia , Animais , Bovinos , Linhagem Celular , Eletrofisiologia , Humanos , Isomerismo , Rim/efeitos dos fármacos , Rim/metabolismo , Cinética , Técnicas de Patch-Clamp , Receptores Pré-Sinápticos/efeitos dos fármacos , Transmissão Sináptica/efeitos dos fármacos , Transfecção
6.
Psychopharmacology (Berl) ; 145(3): 251-9, 1999 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10494573

RESUMO

RATIONALE: Chronic treatment with benzodiazepines results in tolerance to their sedative and anxiolytic effects and there is considerable evidence that different mechanisms underlie the development of tolerance to different behavioural effects. OBJECTIVE: The purpose of the present experiment was to compare the behavioural effects of chronic treatment with diazepam (15 mg/kg per day) given as daily subcutaneous injections or by osmotic minipump. Both regimens resulted in continual receptor occupancy, but the daily injections also provided a period of higher brain concentrations. METHODS: Rats were tested in the holeboard, which provides measures of exploration and locomotor activity, and in the elevated plus-maze and social interaction tests of anxiety. For those in the subcutaneous injection group the tests were 2 h after injection, when brain concentrations were highest. RESULTS: Despite a higher brain concentration in the injected group, both groups showed tolerance to diazepam's sedative effects, after 7 days of treatment. In contrast, in the elevated plus-maze, there was tolerance to the anxiolytic effects in the pump group after 14 days, but a persisting anxiolytic effect in the injected group at 14 and 28 days. Whilst higher brain concentrations could explain this result in the plus-maze, they cannot account for the pattern observed in the social interaction test, where the injection group showed a significant anxiogenic effect at 28 days. CONCLUSIONS: Whereas the mechanism underlying tolerance to the sedative effects of diazepam was insensitive to the different treatment regimens, the results suggest that different adaptive mechanisms were triggered in the two tests of anxiety with a differential sensitivity to the treatment regimen. The adaptive mechanism predominating in the social interaction test was favoured by the injection regimen which produced intermittent peak concentrations. This mechanism seems to be an oppositional one, leading to an anxiogenic response, which was manifest despite high brain concentrations of diazepam at the time of testing.


Assuntos
Ansiolíticos/farmacologia , Diazepam/farmacologia , Tolerância a Medicamentos , Hipnóticos e Sedativos/farmacologia , Animais , Ansiolíticos/administração & dosagem , Córtex Cerebral/efeitos dos fármacos , Córtex Cerebral/metabolismo , Diazepam/administração & dosagem , Hipnóticos e Sedativos/administração & dosagem , Injeções Subcutâneas , Relações Interpessoais , Masculino , Aprendizagem em Labirinto/efeitos dos fármacos , Atividade Motora/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley
7.
J Pharmacol Toxicol Methods ; 36(1): 29-31, 1996 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-8872916

RESUMO

The functional integrity of Alzet osmotic minipumps was assessed using two organic solvents (50% (v/v) dimethyl sulfoxide (DMSO)/50% (v/v) propylene glycol (PG) and 100% tetraglycol) which dissolve diazepam, an aqueous insoluble benzodiazepine. Both solvents showed a significant decrease in output rate over time: the decline with tetraglycol was, however, more marked and variable. Further, the DMSO/PG vehicle demonstrated a comparable decline in rate (1.45%) to that of the control vehicles saline and water (1.12%). DMSO/PG is therefore a suitable solvent for the chronic delivery of diazepam from osmotic minipumps.


Assuntos
Diazepam/administração & dosagem , Dimetil Sulfóxido/administração & dosagem , Bombas de Infusão Implantáveis , Propilenoglicóis/administração & dosagem , Animais , Propilenoglicol , Ratos , Solventes
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA